Literature DB >> 9260859

The geographic distribution of Parkinson's disease mortality in the United States.

D J Lanska1.   

Abstract

PURPOSE: This study examines geographic variation in reporting of Parkinson's disease mortality in the U.S.
METHODS: National Center for Health Statistics and Bureau of the Census data were used to map age-adjusted, race- and race-gender-specific Parkinson's disease mortality rates in the U.S. for 1988.
RESULTS: Among whites, high underlying-cause rates predominated in the North and low rates predominated in the South, whereas high contributing and all-cause rates were concentrated in the northeastern U.S. Strong north-to-south decreasing gradients were present for both underlying- and all-cause rates for whites, regardless of gender, whereas a clear west-to-east gradient could not be demonstrated. Geographic variation in contributing- and all-cause rates was partially explained by variation in tendency to report contributing causes of death. Reported rates among blacks were significantly lower than among whites. There was no latitudinal or longitudinal gradient of underlying-cause rates for blacks, but there was a relatively weak north-to-south decreasing gradient of all-cause rates for blacks, regardless of gender.
CONCLUSIONS: The large-scale pattern of underlying-cause Parkinson's disease mortality among whites has persisted for over three decades.

Entities:  

Mesh:

Year:  1997        PMID: 9260859     DOI: 10.1016/s0022-510x(97)05371-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

Review 1.  Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson's disease.

Authors:  Julie K Andersen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

2.  Synergistic effects of environmental risk factors and gene mutations in Parkinson's disease accelerate age-related neurodegeneration.

Authors:  Jun Peng; May Lin Oo; Julie K Andersen
Journal:  J Neurochem       Date:  2010-11-04       Impact factor: 5.372

3.  Racial differences in Parkinson's disease medication use in the reasons for geographic and racial differences in stroke cohort: a cross-sectional study.

Authors:  Talene A Yacoubian; George Howard; Brett Kissela; Charles D Sands; David G Standaert
Journal:  Neuroepidemiology       Date:  2009-11-04       Impact factor: 3.282

4.  Outdoor work and risk for Parkinson's disease: a population-based case-control study.

Authors:  Line Kenborg; Christina F Lassen; Beate Ritz; Eva S Schernhammer; Johnni Hansen; Nicole M Gatto; Jørgen H Olsen
Journal:  Occup Environ Med       Date:  2010-09-30       Impact factor: 4.402

Review 5.  Prevalence of Parkinson's disease in populations of African ancestry: a review.

Authors:  Aideen McInerney-Leo; Katrina Gwinn-Hardy; Robert L Nussbaum
Journal:  J Natl Med Assoc       Date:  2004-07       Impact factor: 1.798

6.  Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries.

Authors:  Allison Wright Willis; Bradley A Evanoff; Min Lian; Susan R Criswell; Brad A Racette
Journal:  Neuroepidemiology       Date:  2010-01-15       Impact factor: 3.282

7.  Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation.

Authors:  Jun Peng; Fang Feng Stevenson; May Lin Oo; Julie K Andersen
Journal:  Free Radic Biol Med       Date:  2008-11-07       Impact factor: 7.376

8.  Developmental pesticide models of the Parkinson disease phenotype.

Authors:  Deborah A Cory-Slechta; Mona Thiruchelvam; Brian K Barlow; Eric K Richfield
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

9.  Mortality in levodopa-treated Parkinson's disease.

Authors:  John C Morgan; Lillian J Currie; Madaline B Harrison; James P Bennett; Joel M Trugman; G Frederick Wooten
Journal:  Parkinsons Dis       Date:  2014-01-28

Review 10.  The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2016-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.